One MySuper product, AMG MySuper, which has been closed to new members since 2022, failed APRA’s test for the third year in a row, with the trustee planning to discontinue the product. By comparison, five MySuper products failed in 2022 and 13 failed in 2021. Trustees cannot accept new members into products that have failed for two consecutive years.
Cole said evaluating the performance of people’s self-selected super funds was a more nuanced task than for default MySuper products.
“Members in trustee-directed products make active decisions about their investment options and some might select products for reasons beyond performance,” she said. “Nevertheless, all trustees must take responsibility for the products they make available and ensure the products they offer are in their members’ best financial interests.”
Platform trustee-directed products are those offered through software allowing customers to choose from a variety of different investment options, known as platforms. This group of products charged the highest median administration fees and costs at 0.54 per cent of assets compared to 0.27 per cent for non-platform trustee-directed products and 0.26 per cent for the default MySuper products.
Trustees of products that failed to pass the benchmarks are required to notify their members of the test outcomes by September 28, 2023.
An Australian Retirement Trust spokesperson said the company was disappointed its QSuper Socially Responsible option failed the performance test and intended to close the product after this financial year.
Financial Services Council chief executive Blake Briggs called on the government to update its capital gains tax processes to make it easier for consumers to move their money away from disappointing trustee-directed super funds.
“Consumers in impacted products will be told their investment is underperforming, however many will be unable to move out of that investment due to tax reasons,” he said.